Growth kinetics in von hippel-lindau-associated renal cell carcinoma

Urologia Internationalis

Volumn 88, Issue 1, 2012, Pages 71-78

  Jilg, C A ^a   Neumann, H P ^a   Glasker S ^a   Schafer O ^a   Ardelt, P U ^a   Schwardt, M ^a   Schultze Seemann, W ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Growth kinetics; Kidney cancer; Renal cell carcinoma; Von Hippel Lindau disease

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR VOLUME; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; ADULT; AGED; CARCINOMA, RENAL CELL; CELL PROLIFERATION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERM-LINE MUTATION; GERMANY; HUMANS; KIDNEY DISEASES, CYSTIC; KIDNEY NEOPLASMS; KINETICS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PHENOTYPE; PROGNOSIS; TOMOGRAPHY, X-RAY COMPUTED; TUMOR BURDEN; VON HIPPEL-LINDAU TUMOR SUPPRESSOR PROTEIN; YOUNG ADULT;

EID: 84856427197     PISSN: 00421138     EISSN: 14230399     Source Type: Journal    
DOI: 10.1159/000333348     Document Type: Article

References (43)

1. Karsdorp N, Elderson A, Wittebol-Post D, Hene RJ, Vos J, Feldberg MA, et al: Von Hippel-Lindau disease: new strategies in early detection and treatment. Am J Med 1994;97:158-168.
2. Gnarra JR, Glenn GM, Latif F, Anglard P, Lerman MI, Zbar B, et al: Molecular genetic studies of sporadic and familial renal cell carcinoma. Urol Clin North Am 1993;20:207-216.
3. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, et al: Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-1320.
4. Neumann HP, Wiestler OD: Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet 1991;337:1052-1054.
5. Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, et al: Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 1994;55:1092-1102.
6. Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, et al: Patterns of gene expression and copy-number alterations in von Hippel-Lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res 2009;69:4674-4681.
7. Nickerson ML, Jaeger E, Shi Y, Durocher JA, Mahurkar S, Zaridze D, et al: Improved identification of von Hippel-Lindau gene alterations in clear cell renal tumors. Clin Cancer Res 2008;14:4726-4734.
8. Young AC, Craven RA, Cohen D, Taylor C, Booth C, Harnden P, et al: Analysis of VHL gene alterations and their relationship to clinical parameters in sporadic conventional renal cell carcinoma. Clin Cancer Res 2009;15:7582-7592.
9. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, et al: Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 2003;21:577-581.
10. Beroud C, Joly D, Gallou C, Staroz F, Orfanelli MT, Junien C: Software and database for the analysis of mutations in the VHL gene. Nucleic Acids Res 1998;26:256-258.
11. Nordstrom-O'Brien M, van der Luijt RB, van Rooijen E, van den Ouweland AM, Majoor-Krakauer DF, Lolkema MP, et al: Genetic analysis of von Hippel-Lindau disease. Hum Mutat 2010;31:521-537.
12. Maher ER, Neumann HP, Richard S: Von Hippel-Lindau disease: a clinical and scientific review. Eur J Hum Genet 2011;19:617-623.
13. Neumann HP, Bender BU, Berger DP, Laubenberger J, Schultze-Seemann W, Wetterauer U, et al: Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol 1998;160:1248-1254.
14. Verine J, Pluvinage A, Bousquet G, Lehmann-Che J, de Bazelaire C, Soufir N, et al: Hereditary renal cancer syndromes: an update of a systematic review. Eur Urol 2010;58:701-710.
15. Choyke PL, Glenn GM, Walther MM, Zbar B, Weiss GH, Alexander RB, et al: The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. AJR Am J Roentgenol 1992;159:1229-1234.
16. Joly D, Mejean A, Correas JM, Timsit MO, Verkarre V, Deveaux S, et al: Progress in nephron-sparing therapy for renal cell carcinoma and von Hippel-Lindau disease. J Urol 2011;185:2056-2060.
17. Linehan WM, Grubb RL, Coleman JA, Zbar B, Walther MM: The genetic basis of cancer of kidney cancer: implications for gene-specific clinical management. BJU Int 2005;95(suppl 2):2-7.
18. Ploussard G, Droupy S, Ferlicot S, Ples R, Rocher L, Richard S, et al: Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease. Urology 2007;70:435-439.
19. Walther MM, Choyke PL, Glenn G, Lyne JC, Rayford W, Venzon D, et al: Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal-sparing surgery. J Urol 1999;161:1475-1479.
20. Walther MM, Lubensky IA, Venzon D, Zbar B, Linehan WM: Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol 1995;154:2010-2014.
21. Neumann HP, Eggert HR, Scheremet R, Schumacher M, Mohadjer M, Wakhloo AK, et al: Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatry 1992;55:898-901.
22. Erlic Z, Hoffmann MM, Sullivan M, Franke G, Peczkowska M, Harsch I, et al: Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome. J Clin Endocrinol Metab 2010;95:308-313.
23. Jones TB, Riddick LR, Harpen MD, Dubuisson RL, Samuels D: Ultrasonographic determination of renal mass and renal volume. J Ultrasound Med 1983;2:151-154.
24. Emamian SA, Nielsen MB, Pedersen JF, Ytte L: Kidney dimensions at sonography: correlation with age, sex, and habitus in 665 adult volunteers. AJR Am J Roentgenol 1993;160:83-86.
25. Ozono S, Miyao N, Igarashi T, Marumo K, Nakazawa H, Fukuda M, et al: Tumor doubling time of renal cell carcinoma measured by CT: collaboration of Japanese Society of Renal Cancer. Jpn J Clin Oncol 2004;34:82-85.
26. Lee JY, Kim CK, Choi D, Park BK: Volume doubling time and growth rate of renal cell carcinoma determined by helical CT: a singleinstitution experience. Eur Radiol 2008;18:731-737.
27. Zhang J, Kang SK, Wang L, Touijer A, Hricak H: Distribution of renal tumor growth rates determined by using serial volumetric CT measurements. Radiology 2009;250:137-144.
28. Frank I, Blute ML, Leibovich BC, Cheville JC, Lohse CM, Zincke H: Independent validation of the 2002 American Joint Committee on cancer primary tumor classification for renal cell carcinoma using a large, singleinstitution cohort. J Urol 2005;173:1889-1892.
29. Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG: The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. J Urol 2006;175:425-431.
30. Volpe A, Jewett MA: The natural history of small renal masses. Nat Clin Pract Urol 2005;2:384-390.
31. Birnbaum BA, Bosniak MA, Megibow AJ, Lubat E, Gordon RB: Observations on the growth of renal neoplasms. Radiology 1990;176:695-701.
32. Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, et al: The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol 2004;172:63-65.
33. Herring JC, Enquist EG, Chernoff A, Linehan WM, Choyke PL, Walther MM: Parenchymalsparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol 2001;165:777-781.
34. Jewett MA, Mattar K, Basiuk J, Morash CG, Pautler SE, Siemens DR, et al: Active surveillance of small renal masses: progression patterns of early stage kidney cancer. Eur Urol 2011;60:39-44.
35. Kragel PJ, Walther MM, Pestaner JP, Filling-Katz MR: Simple renal cysts, atypical renal cysts, and renal cell carcinoma in von Hippel-Lindau disease: a lectin and immunohistochemical study in six patients. Mod Pathol 1991;4:210-214.
36. Solomon D, Schwartz A: Renal pathology in von Hippel-Lindau disease. Hum Pathol 1988;19:1072-1079.
37. Montani M, Heinimann K, von Teichman A, Rudolph T, Perren A, Moch H: VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease. Am J Surg Pathol 2010;34:806-815.
38. Gallou C, Chauveau D, Richard S, Joly D, Giraud S, Olschwang S, et al: Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions. Hum Mutat 2004;24:215-224.
39. Gallou C, Joly D, Mejean A, Staroz F, Martin N, Tarlet G, et al: Mutations of the VHL gene in sporadic renal cell carcinoma: definition of a risk factor for VHL patients to develop an RCC. Hum Mutat 1999;13:464-475.
40. Franke G, Bausch B, Hoffmann MM, Cybulla M, Wilhelm C, Kohlhase J, et al: Alu-Alu recombination underlies the vast majority of large VHL germline deletions: molecular characterization and genotype-phenotype correlations in VHL patients. Hum Mutat 2009;30:776-786.
41. Maranchie JK, Afonso A, Albert PS, Kalyandrug S, Phillips JL, Zhou S, et al: Solid renal tumor severity in von Hippel-Lindau disease is related to germline deletion length and location. Hum Mutat 2004;23:40-46.
42. Ong KR, Woodward ER, Killick P, Lim C, Macdonald F, Maher ER: Genotype-phenotype correlations in von Hippel-Lindau disease. Hum Mutat 2007;28:143-149.
43. Forman JR, Worth CL, Bickerton GR, Eisen TG, Blundell TL: Structural bioinformatics mutation analysis reveals genotype-phenotype correlations in von Hippel-Lindau disease and suggests molecular mechanisms of tumorigenesis. Proteins 2009;77:84-96.